Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Savara Inc
(NQ:
SVRA
)
4.510
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2
Open
4.510
Bid (Size)
3.930 (3)
Ask (Size)
5.560 (2)
Prev. Close
4.510
Today's Range
4.510 - 4.510
52wk Range
3.115 - 5.700
Shares Outstanding
114,066,080
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Savara to Present New Data from Pivotal Phase 3 IMPALA-2 Trial of Molgramostim Nebulizer Solution (Molgramostim) in Patients with Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the European Respiratory Society (ERS) Congress 2024
August 15, 2024
From
Savara Inc.
Via
Business Wire
SVRA Stock Earnings: Savara Misses EPS for Q2 2024
August 12, 2024
SVRA stock results show that Savara missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Performance
YTD
+3.20%
+3.20%
1 Month
-9.07%
-9.07%
3 Month
-4.45%
-4.45%
6 Month
-9.26%
-9.26%
1 Year
+27.04%
+27.04%
More News
Read More
Savara Reports Second Quarter 2024 Financial Results and Provides Business Update
August 12, 2024
From
Savara Inc.
Via
Business Wire
Savara Announces Pricing of $100.0 Million Underwritten Offering of Common Stock
June 28, 2024
From
Savara Inc.
Via
Business Wire
SVRA Stock Earnings: Savara Misses EPS for Q1 2024
May 09, 2024
Via
InvestorPlace
Why Is Respiratory Disease-Focused Savara Stock Trading Higher On Wednesday?
June 26, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
June 26, 2024
Via
InvestorPlace
Savara Announces Molgramostim Nebulizer Solution (Molgramostim) Achieved Statistical Significance for Primary Endpoint and Multiple Secondary Endpoints in IMPALA-2, a Pivotal Phase 3 Clinical Trial in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
June 26, 2024
From
Savara Inc.
Via
Business Wire
SVRA Stock Earnings: Savara Beats EPS for Q4 2023
March 07, 2024
Via
InvestorPlace
Savara Inc. (NASDAQ: SVRA) Making Surprising Moves in Monday Session
February 26, 2024
Via
Investor Brand Network
Savara to Host Investor Call to Discuss Top Line Results From Pivotal Phase 3 IMPALA-2 Trial of Molgramostim Nebulizer Solution (Molgramostim) in Patients With Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
June 25, 2024
From
Savara Inc.
Via
Business Wire
3 Penny Stocks Poised for Major Upside Over the Next 5 Years
June 19, 2024
Via
InvestorPlace
3 Penny Stocks That Can Deliver Over 5,000% Upside by 2025: June Edition
June 11, 2024
Via
InvestorPlace
Savara to Present at the Jefferies Global Healthcare Conference
May 29, 2024
From
Savara Inc.
Via
Business Wire
Savara Presented New Data on Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the American Thoracic Society (ATS) International Conference 2024
May 19, 2024
From
Savara Inc.
Via
Business Wire
Savara Announces New Employment Inducement Grant
May 16, 2024
From
Savara Inc.
Via
Business Wire
Savara Reports First Quarter 2024 Financial Results and Provides Business Update
May 09, 2024
From
Savara Inc.
Via
Business Wire
Savara to Present at the Citizens JMP Life Sciences Conference
May 07, 2024
From
Savara Inc.
Via
Business Wire
Savara to Present New Data on Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the American Thoracic Society (ATS) International Conference 2024
April 08, 2024
From
Savara Inc.
Via
Business Wire
Savara Announces New Employment Inducement Grant
March 22, 2024
From
Savara Inc.
Via
Business Wire
Savara Reports Fourth Quarter/Year-End 2023 Financial Results and Provides Business Update
March 07, 2024
From
Savara Inc.
Via
Business Wire
Savara to Present at the Barclays 26th Annual Global Healthcare Conference
March 06, 2024
From
Savara Inc.
Via
Business Wire
Savara Announces New Employment Inducement Grant
February 02, 2024
From
Savara Inc.
Via
Business Wire
Savara to Present at Two Upcoming Healthcare Conferences
January 31, 2024
From
Savara Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 16, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.